Roche Diagnostics Corporation Confirm Anti-Pr (1e2) 250

Roche Diagnostics Corporation confirm anti-pr (1e2) 250; this antibody is intended for in vitro diagnostic (ivd) use. confirm anti-progesterone receptor (pr) (1e2) rabbit monoclonal (igg) is intended for laboratory use for the qualitative detection of progesterone receptor (pr) antigen in sections of formalin-fixed, paraffin-embedded tissue on a ventana automated slide stainer with ventana detection kits and ancillary reagents. confirm anti-pr (1e2) is directed against an epitope present on human progesterone receptor protein located in the nucleus of pr positive normal and neoplastic cells. confirm anti-pr (1e2) is indicated as an aid in the management, prognosis, and prediction of therapy outcome of breast carcinoma. this product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. prescription use only. - ROCHMSD (Additional S&H or Hazmat Fees May Apply)